An International Study on Pediatric Patients With Rare Tumors.

Recruiting now

Conditions studied: Paraganglioma/ Phaeochromocytoma, Melanoma and Other Malignant Neoplasms of Skin, Gastrointestinal Stromal Tumor (GIST), Adrenocortical Tumor, Pancreatic Tumors, Esthesioneuroblastoma, Olfactory, Mesothelioma, Nasopharyngeal Carcinoma (NPC), NUT Carcinoma, Pleuropulmonary Blastoma, Salivary Gland Tumors, Thymic Tumors, Thyroid Carcinoma, Appendiceal Cancers

In brief

The PARTNER study is an international, prospective, observational study of paediatric patients with very rare tumours.

Key facts

Study ID

NCT07072143

Run by

Azienda Ospedaliera di Padova

People needed

6250

Starts

2025-01-25

Expected to finish

2049-06-06

Last updated by the study team

2025-07-18

Who can join

Age: any, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Children and adolescents (age 0-18 years) with a primary or relapsed Very Rare Tumor diagnosed and/or treated in a participating country/center.
• Written informed consent from the patient and/or the parent/legal guardian

You may not qualify if…

• Absence of Written informed consent from the patient and/or the parent/legal guardian

Where it is running

• Pediatric Oncology Unit, University Hospital Padova [AOUP Azienda Ospedale Università Padova] — Padova, Italy, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.